Larouche V, Snell L, Morris D V
Resident, Internal Medicine Residency Training Program, Department of Medicine, McGill University , Montreal, Quebec , Canada.
Division of General Internal Medicine, McGill University Health Centre , Montreal, Quebec, H4A 3J1 , Canada.
Endocrinol Diabetes Metab Case Rep. 2015;2015:150087. doi: 10.1530/EDM-15-0087. Epub 2015 Sep 2.
Myxoedema madness was first described as a consequence of severe hypothyroidism in 1949. Most cases were secondary to long-standing untreated primary hypothyroidism. We present the first reported case of iatrogenic myxoedema madness following radioactive iodine ablation for Graves' disease, with a second concurrent diagnosis of primary hyperaldosteronism. A 29-year-old woman presented with severe hypothyroidism, a 1-week history of psychotic behaviour and paranoid delusions 3 months after treatment with radioactive iodine ablation for Graves' disease. Her psychiatric symptoms abated with levothyroxine replacement. She was concurrently found to be hypertensive and hypokalemic. Primary hyperaldosteronism from bilateral adrenal hyperplasia was diagnosed. This case report serves as a reminder that myxoedema madness can be a complication of acute hypothyroidism following radioactive iodine ablation of Graves' disease and that primary hyperaldosteronism may be associated with autoimmune hyperthyroidism.
Psychosis (myxoedema madness) can present as a neuropsychiatric manifestation of acute hypothyroidism following radioactive iodine ablation of Graves' disease.Primary hyperaldosteronism may be caused by idiopathic bilateral adrenal hyperplasia even in the presence of an adrenal adenoma seen on imaging.Adrenal vein sampling is a useful tool for differentiating between a unilateral aldosterone-producing adenoma, which is managed surgically, and an idiopathic bilateral adrenal hyperplasia, which is managed medically.The management of autoimmune hyperthyroidism, iatrogenic hypothyroidism and primary hyperaldosteronism from bilateral idiopathic adrenal hyperplasia in patients planning pregnancy includes delaying pregnancy 6 months following radioactive iodine treatment and until patient is euthyroid for 3 months, using amiloride as opposed to spironolactone, controlling blood pressure with agents safe in pregnancy such as nifedipine and avoiding β blockers.Autoimmune hyperthyroidism and primary hyperaldosteronism rarely coexist; any underlying mechanism associating the two is still unclear.
黏液性水肿性疯狂最早于1949年被描述为严重甲状腺功能减退的后果。大多数病例继发于长期未经治疗的原发性甲状腺功能减退。我们报告首例放射性碘消融治疗格雷夫斯病后发生医源性黏液性水肿性疯狂的病例,同时并发原发性醛固酮增多症。一名29岁女性在接受放射性碘消融治疗格雷夫斯病3个月后出现严重甲状腺功能减退,伴有1周的精神病行为和偏执妄想病史。她的精神症状在左甲状腺素替代治疗后缓解。同时发现她患有高血压和低钾血症。诊断为双侧肾上腺增生所致的原发性醛固酮增多症。本病例报告提醒我们,黏液性水肿性疯狂可能是格雷夫斯病放射性碘消融后急性甲状腺功能减退的并发症,原发性醛固酮增多症可能与自身免疫性甲状腺功能亢进有关。
精神病(黏液性水肿性疯狂)可表现为格雷夫斯病放射性碘消融后急性甲状腺功能减退的神经精神表现。原发性醛固酮增多症可能由特发性双侧肾上腺增生引起,即使影像学检查发现肾上腺腺瘤。肾上腺静脉采样是区分需手术治疗的单侧醛固酮分泌腺瘤和需药物治疗的特发性双侧肾上腺增生的有用工具。计划怀孕的患者中,自身免疫性甲状腺功能亢进、医源性甲状腺功能减退和双侧特发性肾上腺增生所致原发性醛固酮增多症的管理包括放射性碘治疗后延迟怀孕6个月,直至患者甲状腺功能正常3个月,使用阿米洛利而非螺内酯,用孕期安全的药物如硝苯地平控制血压并避免使用β受体阻滞剂。自身免疫性甲状腺功能亢进和原发性醛固酮增多症很少共存;两者相关的任何潜在机制仍不清楚。